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INTRODUCTION
              In the last decade of 20th century, the pool of resources and information 
available to support medical & surgical teams in neonatal pain management has 
expanded rapidly1.
             One of the institutional practical guidelines and standards of care should 
include “ a patient’s right to regular and systemic assessment of pain, interventions 
to relieve pain, evaluation of effectiveness of interventions, attention to long term 
pain management needs, deleterious effects of unmanaged pain, and educational 
needs of families and staff who provide care”2,3,4.
            Despite these initiatives, surveys of physicians and nurses continue to suggest 
that  pain  in  the  neonatal  population  is  underestimated  and  under  managed  even  in 
western countries 5 6,7.
           Various studies state that infants born at 27 to 31 weeks of gestation may 
experience as many as 134 painful procedures in the first 2 weeks of life8.
            The prevention of pain in neonates is an expectation of parents. Not only it is an 
ethical expectation, but also because the stress induced by the pain response, produce 
sequelae in multiple organ systems.
          Acute  effects  include  elevations  of  cortisol,  catecholamines  and  lactate, 
hypertension,  tachycardia,  respiratory  instability,  glucose  instability  and  changes  in 
cerebral blood flow.  
          Chronic pain may affect growth, immune function, recovery and discharge.
          Neonatal  pain  also  influences  long  term  memory,  social  and  cognitive 
development and neuro plasticity9, 10.
            Neonates at greatest risk of neurodevelopmental impairment as a result of 
preterm birth  (i.e.,  the  smallest  and sick  neonates)  are  also  those  most  likely  to  be 
exposed to the greatest number of painful stimuli, creating a double hit phenomenon11.
          Because the most effective and safest ways to prevent pain in the neonate are 
unknown,  striking  a  proper  balance  between  effective  pain  relief  and  avoidance  of 
serious adverse effects from pain medications is a major challenge12, 13, and 14. 
          This study is designed to assess the pain response of the neonate and compare the 
efficacy of various non-pharmacological methods in reliving pain, due to venipuncture 
using a multidimensional tool.
         The most useful and feasible one is incorporated in the hospital policy.
                
REVIEW OF LITERATURE
Physiology of pain perception in neonates
          By 20 weeks of gestation, the fetus is served by a highly differentiated and fully 
functional sensory system, as evidenced by presence of nociceptive nerve endings in the 
skin,  arborization  of  dendritic  processes  in  the  neocortex  and  synaptogenesis  of 
thalamocortical fibers15.    
        The functional maturity of pain pathway is evidenced by the presence of various 
neurotransmitters  and  pain  related  neuromodulator  substances  like  substance  p, 
somatostatin, calcitonin gene regulated peptide (CGRP) and vasoactive peptides.
        The large number of nociceptive nerve endings in the skin and mucous membranes 
of the fetus far exceed that in adults.
        Nociceptive impulses in babies travel to the spinal cord through unmyelinated 
rather  than  myelinated  fibers  and  there  is  also  a  relative  paucity  of  inhibitory 
neurotransmitter in them. Babies also have large receptive fields and possibly a higher 
concentration of substance p receptors. They have a lower threshold for excitation and 
sensitization, resulting in more central effects of nociceptive stimuli. These factors are 
believed to make infants feel pain more severely than older persons1, 15.
Ascending pathways between the  peripheral  nervous  system and spinal  cord  rich  in 
excitatory neurotransmitter, which potentiate pain transmission, but poor in mediating 
neurotransmitters which blunt the pain response.
          There is no doubt that newborn babies do feel pain as evidenced by variety of 
facial,  behavioral,  autonomic,  biochemical  [hypoglycemia,  rise  in  serum  lactate& 
pyruvate], hormonal response and even rise in pulmonary artery pressure leading to right 
to left shunt. 
             Neonates also harbor unpleasant memories of pain in later life.
                Although development of complex structures of the central nervous system 
parallels that in the peripheral nervous system and a vast supply of neurons purveys the 
cortex itself, differentiation of structure and function in the cortex is a slower process 
and compromises preterm infants ability to integrate and assimilate pain information. 
Their response patterns both physiologic and behavioral are less organized, less robust 
less ordinate and more difficult to interpret.  50% of premature infants do not cry during 
painful procedures.
          Local tissue injury resulting from repeated heel sticks and invasive procedures 
trigger  increased  proliferation  of  nerve  endings  in  surrounding  tissues  may  remain 
hypersensitive well beyond the neonatal period16.
                        
Mechanisms of pain perception and pain suppression:
   
                The periaqueductal grey and periventricular mesencephalic regions serve as an 
inherent analgesic system. Signals from these regions are transmitted through nuclei in 
the pons and medulla, to the dorsal horn of the spinal cord, to block the sensation of 
pain.
              The neurotransmitters involved in the suppression of are endogenous opiates 
that include b-endorphin, met and leu encephalins and dynorphin.
Other neurotransmitters such as  serotonin and GABA also decrease the sensation of 
pain17.
Possible reasons for the neglect of pain relief in neonates:
1. Lack of awareness of neonate’s capability to perceive pain.
2. Lack of awareness of clinical situations where in pain is perceived.
3. Inability of infants to express pain specifically.
4. Medical attention focused towards treatment of primary clinical condition.
5. Neonates’ expression of pain interpreted as expressions of fear.
6. Caregivers’ temptation to perform quick procedures without analgesia.
7. Reluctance to use analgesics due to side effects.
8. Fear of inducing dependence on opioid drugs.
9. Lack of awareness of painless routes and methods of analgesia17.
ASSESSMENT OF PAIN
          Although self-reporting of pain is the gold standard for assessment of the site, 
nature  and  severity  of  pain,  it  is  not  precisely  applicable  in  neonates.  Hence  in 
neonates,  surrogate  markers  are  used.  Pain  is  associated  with  physiological, 
biochemical, behavioral, and psychological alterations that can be recorded and some 
extent, quantified18. These changes are as follows,
 Physiological changes:
 Increase in
1. Heart rate
2. Blood pressure
3. Respiratory rate
4. Oxygen consumption
5. Mean airway pressure
6. Muscle tone
7. Intracranial pressure
Autonomic changes:
          1.Mydriasis
2.Sweating
3.Flushing
4.Pallor
Behavioral changes:
Change in facial expression 
        1.Grimacing
2.Screwing up of eyes
3.Nasal flaring
4.Deep nasolabial groove
5.Curving of the tongue
6.Quivering of the chin
Body movements:
1. Finger clenching
2. Thrashing of limbs
3. Writhing
4. Arching of back
5. Head banging
Biochemical changes:
Increased release of:
1. Cortisol
2. Catecholamines
3. Glucagons
4. Growth hormone
5. Rennin
6. Aldosterone
7. Antidiuretic hormone
Decreased secretion of:
     1.Insulin.
               It is reported that 20% increase in the measurable physiological parameters in 
response to pain. These changes are secondary to increased cortisol and catecholamine 
secretion, which sets up the classical fight  and flight sequence in older children and 
adults. It is easy to measure alterations in most of the physiological parameters without 
invasive equipment.
             These measurements coupled with certain consistent behavioral responses are 
very sensitive   indicators of newborn pain. Of the behavioral changes facial expression 
of  the  baby  is  considered  the  most  reliable  and  consistent  indicator,  with  the  least 
interobserver disagreement as well19.
            Although the biochemical changes are perhaps the most sensitive quantifiable 
parameters, the need to use invasive methods is a major drawback.
Consequences of pain in infants:
   Immediate effects:
• Irritability
• Fear
• Disturbance of sleep and wakefulness state
• Increased oxygen consumption
• Ventilation-perfusion mismatch
• Diminished nutrient intake
• Increased gastric acidity.
  Short-term effects:
• Enhanced catabolism
• Altered immunological function
• Delayed healing
• Impaired emotional bonding
Long-term effects:
• Memory pain
• Developmental retardation
• Alteration in response to subsequent painful experience.
MANAGEMENT OF PAIN:
       The management of infant pain rests primarily on the tripod of 
1. Awareness of infants’ capacity to perceive pain.
2. Sensitivity to situations where infants may experience pain may be encountered
3. Appropriate steps to prevent and treat pain17.
Basis management strategies for infant pain
• Awareness of infants’ capacity to perceive pain.
• Sensitivity to situations where infants may experience pain
• Prevention of pain.
• Assessment of cause and severity of pain
• Pharmacological interventions
• Non-pharmacological interventions.
• Modification of techniques used for diagnostic and therapeutic procedures.
  Pharmacological interventions
  Systemic administration of drugs: 
  
        The  opioids, including morphine, methadone, oxymorphine, codeine, fentanyl, 
alfentanil, and sufentanil are the most potent class of analgesic drugs. They have the 
added advantage of this group is that in the event of over dosage, the effects are easily 
reversed. These drugs have the potential for tolerance and dependence. Risk of adverse 
effects like respiratory and central nervous system depression, often hampers the rational 
use of these agents20.
      Non-steroidal anti-inflammatory drugs are used to treat pain of lesser intensity 
and as an adjunct to reduce the total dose of opioids.
Local techniques
              Local anesthetic agents block the transmission of impulses from receptors to the 
spinal cord. They can be administered in any one of three ways:
1. Infiltration into local area
2. Nerve blockade
3. Intravenous regional block
           Various  local  anesthetic  agents  available  are  lignocaine  preparations, 
bupivacaine, amethocaine gel, and ropivacaine. Mixing  with the adrenaline increases 
the duration of action21.
          A eutectic mixture of 2.5% lignocaine and 2.5% prilocaine, designated EMLA is 
becoming popular. A mixture of tetracaine, amethocaine and cocaine(TAC) in another 
local anesthetic22.
Non-pharmacological interventions:
             These are interventions that enhance activity in descending inhibitory systems 
and there by decrease pain perception. Attenuation of transmission of impulses to  the 
spinal  cord  can  be  achieved  by  stimulation  of  large  sensory  nerve  fibers  mediating 
sensations of touch and temperature.
            The non-pharmacological interventions may also modulate pain sensation and 
response to pain through changes in attention and decreasing apprehension. 
           Some of the strategies are as follows,
• Facilitated tucking--- positioning and restraining the infant in a relatively flexed 
posture23.
• Stroking---stimulation of nerve fibers transmitting tactile and thermal sensations.
• Combining these methods with soothing vocal stimulation24.
• Breast feeding25, 26
• Feeding of sweet compounds such as sucrose27, glucose28, 29 and saccharine.
•  Non-nutritive sucking on pacifiers31, 32.
• Kangaroo care---skin to skin contact
• Gentle rocking
• Swaddling
• Development  care,  which  includes  limiting  environmental  stimuli,  lateral 
positioning, the use of supportive bedding, and attention to behavioral clues.
             Oral sucrose eliminates the electroencephalographic changes associated with a 
painful procedure in a neonate, but the mechanism of pain relief by sucking oral sucrose 
is not known for certain. In one study, endogenous endorphin concentrations did not 
increase with administration of oral sucrose.
           Although the intra oral administration of sucrose to preterm infants without 
suckling is effective, intragastric administration is not.    
          Concentrated oral glucose has also been used and diminishes the pain response of 
venipuncture,  but  it  does  not  decrease  oxygen  consumption  or  energy  expenditure, 
suggesting there may still be a stress response.
         A wide range of oral sucrose doses have been used in neonates for pain relief, but 
an optimal dose has not been established . 
       The dosage range of sucrose for  reducing pain in neonates is  0.012 to 0.12g 
(0.05-0.5 ml of 24% solution). Some authors have suggested that multiple doses for a 
procedure ( 2 minutes before and 1-2 min after) are more effective than a single dose33, 
34.
        Because oral sucrose reduces but dose not eliminate pain in neonates, it should be 
used with other non-pharmacological measures to enhance its effectiveness.
Clinical settings where in infants experience pain (a partial list) 17:
Disease conditions:
• Otitis media
• Pharyngitis and oral infections
• Aphthous ulcers
• Chestpain associated with coughing
• Infantile colic
• Headache due to variety of causes
• Tissue injury due to trauma
• Hydrocephalus
• Intracranial bleeding
• Necrotising enterocolitis
• Intestinal obstruction
• Spasticity.
Diagnostic procedures:
• Heel puncture
• Venous and arterial puncture
• Suprapubic bladder puncture
• Squeezing muscles during blood sampling
• Lumbar puncture
• Ventricular puncture
• Endotracheal suction
• Bronchoscopy
• Paracentesis thoracis
• Ascitic fluid aspiration
• Gastrointestinal endoscopy
• Cystoscopy
Therapeutic procedures:
• Intravenous cannulation
• Intamuscular injection
• Umbilical catheterization
• Insertion or removal of infant feeding tube
• Urinary bladder catheterization
• Endotracheal intubation and suction
• Circumcision
• Wound dressing
• Incision and drainage procedures
• Postoperative state
• Insertion/ removal of drainage tubes
• Endoscopic sclerotherapy.
Pain assessment scales in infants  17  :  
                       Various pain scales have been designed and validated to assess pain.  
Some of the commonly used scales as follows,
 Based on behavioral changes:
• Neonatal facial coding system (NFCS)
• Infant baby coding system (IBCS)
• Neonatal infant pain scale (NIPS)
• Pain assessment in neonates (PAIN)
• Liverpool infant distress scale (LIDS)
• Modified behavioral pain scale 
• Children’s hospital of eastern Ontario pain scale (CHEOPS)
• Neonatal assessment of pain inventory (NAPI)
• Behavioral pain score
• Clinical scoring system. 
Combination of physiological and behavioral                                         changes:
• CRIES (acronym for crying, change in transcutaneous oxygen saturation, heart 
rate, blood pressure, facial expression and alteration in sleep pattern)
• Pain assessment tool (PAT)
• Premature infant pain profile (PIPP)
• Scale for use in newborns (SUN)
• COMFORT score
The pain assessment tool used should be multidimensional, including measurements for 
both  physiologic  and  behavior  indicators  of  pain.  One  such  tool  is  PREMATURE 
INFANT PAIN PROFILE.
PREMATURE INFANT PAIN PROFILE:
      It is a seven indicator multidimensional tool originally developed to assess acute 
pain  in  term  and  preterm  infants.  Scoring  with  PIPP  is  unique,  is  that  special 
consideration  is  given to  the  infant’s  gestational  age  in  addition  to  physiologic  and 
behavioral indices. Each indicator is evaluated in a scale of 0 to 3, with a total score 
range of 21 for premature infants and 18 for term or older infants.
∗ A score of </= 6 indicates minimal or no pain.
A score of >12 indicates moderate to severe pain1.
Scoring guidelines:
1. Score the corrected gestational age before scoring.
2. Assess baseline heart rate and oxygen saturation;
a. For procedural pain asses before the event
b. If pain is already present, review he chart for earlier base line.
3. Score behavioral state by observing the infants for 15 seconds immediately before 
the event.
4. Observe the infant for 30 seconds immediately after the event35.     
AIM OF THE STUDY
• To  assess  the  magnitude  of  the  pain  response  of  healthy  preterm  and  term 
neonates to venipuncture, objectively. 
• To compare some of the non-pharmacological methods and objectively to find out 
the efficacy of single versus combined non-pharmacological methods.
• To find out the best method(s) to incorporate into the hospital policy.
STUDY JUSTIFICATION
           Though ample numbers of studies were done, related to non-pharmacological 
methods of pain relief, only meager studies are available in our country especially in the 
southern part.
          Only few studies used multidimensional  scale to assess  the pain response 
particularly, the “Premature infant pain profile” – which is one of the well-known and 
accepted multi dimensional scales universally.
         Also only very few studies included preterm in the study.
         Although all  methods have shown promise, no single method is universally 
recommended.
         Though review of literature says that combining two methods is superior to single 
method, the effectiveness of this combination is not proven objectively in most of the 
studies.
        With the above-told justification this study is carried out.
 SUBJECTS AND METHODS
Study design:
        Prospective randomized, partially blinded study.
Study place:
        Post natal ward, post caesarian ward, preterm ward and transitional care unit of the 
Government Raja Mirasudar  Hospital, Thanjavur, which is attached to the Thanjavur 
Medical College Hospital, Thanjavur. 
Study period:
      12 months starting form July 2007 to August 2008.
Study population:
     150 preterm and term neonates  requiring blood sampling  for  blood groping & 
jaundice.
Eligibility criteria:
   Inclusion criteria:
1. Gestational age: Preterm and term newborn babies who established the 
sucking & swallowing coordination.
2. Neonatal age more than 24 hours, less than or equal to 28 days.
Exclusion criteria:
     1.Clinically  ill  (irritable,  poor or incessant  cry, lethargy, refusal  of feeds, 
sluggish neonatal reflexes for the corresponding gestational age, breathlessness, 
unstable vitals).
       2. Major congenital anomalies
3. Risk of sepsis
4. Any sedative or analgesic drug intake
5. Any  other  painful  condition  (Skin  infections,  parenteral  medication, 
immunization)
6. On intravenous fluids.
        Informed consent was obtained from the mother before inclusion of the neonates 
for the study.
       On inclusion, the neonates were randomly assigned to one of the 6 groups by simple 
randomization techniques namely,
1. Control group
2. 24% sucrose solution
3. Rocking
4. Non-nutritive sucking
5. 24% sucrose & Non-nutritive sucking
6. Rocking & Non-nutritive Sucking.
         Neonates in the Control group were given 2ml of distilled water orally 2 min 
before venipuncrure.
        Neonates in the 24% sucrose group were given 2ml of 24% sucrose solution 2 
minutes before the venipuncture.
       In the Rocking group, neonates were rocked by lifting the baby’s head off the cot on 
palm of the hand (without lifting the baby off the cot) and making rocking movements in 
a gentle, rhythmic manner. This was continued during and up till 2 minutes after the 
procedure. 
       A sterile pacifier (standard silicone rubber) was held gently in the neonate’s mouth, 
in the Non-nutritive sucking group and the palate tickled to stimulate sucking. This was 
continued during and up till 2 minutes after venipuncture.
      In the 5th group both 24% sucrose 2 minutes prior to procedure and Non-nutritive 
sucking were given as described above.
     In the 6th group both Rocking and Non-nutritive sucking were given as described 
above.
PROCEDURE:
       The baby was placed in a cot under radiant warmer in a quiet, diffusely lighted 
room. The pulse oximeter probe was attached firmly to the foot. All interventions were 
kept ready for every baby.
      Blinding was achieved by one of the observers ( observer 1) leaving the bedside and 
standing behind a screen.
      The baby was then assigned to one of the groups.
      A trained staff nurse1 gave the selected intervention before or during the procedure 
as described above according to the group.
      Base line parameters like heart rate and oxygen saturation were studied from the 
pulse oximeter for duration of 15 seconds prior to the procedure. 
     The dorsum of the hand was held between the thumb and index finger just tight 
enough to make the vein prominent and venipuncture was done with a 23 G needle by a 
trained staff nurse 2, with instructions to avoid squeezing, manipylation of the needle tip 
or removal reintroduction of the needle during the next 30 seconds during which the 
observer 1 recorded the duration of the facial expressions namely, Eye squeeze, Brow 
bulge and Nasolabial furrowing.
           The observer 2 completed the recording of data like maximal heart rate and 
minimum oxygen saturation in the 30 seconds following the procedure from the pulse 
oximeter in the proforma. The observers were blinded to the group allocation of the 
neonates. 
         Blinding was partial as in some of the groups intervention needed to be continued 
during the venipuncture.  
           The staff nurse then continued and completed the procedure of blood sampling.
          Strict  aseptic precautions were carried during preparation of solutions and 
throughout the procedure.
         The neonates enrolled were followed up at 24 hours and 48 hours to look for any 
possible adverse effects to the administration of oral solution or the other interventions. 
Mothers or the care givers were also to instructed watch for and report immediately, if in 
case  the  neonates  experienced  any  new  symptoms,  bluish  discoloration,  abdominal 
distension, refusal of feeds etc.          
OBSERVATIONS AND RESULTS
STATISTICAL ANALYSIS
          The results were analyzed by using the following statistical analysis.
           Data was analyzed using SPSS version 10.5.
           ANOVA (Analysis of variance) followed by Fischer’s exact ‘t’ test where 
required.
          Multivariate analysis was used for demographic data.
          Pearson’s correlation test was used where required.
RESULTS AND OBSEVATION
          In this study total number of subjects were 150(n). They are randomly divided in 
to 6 groups.
 Among them 88 are female babies and 62 are male babies. Their distribution is as 
follows, 
Table-1
Sex distribution of the total subjects
SEX
88 58.7 58.7 58.7
62 41.3 41.3 100.0
150 100.0 100.0
FEMALE
MALE
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
The majority were female babies 58.7% and male babies are 41.3%
Table-2
Frequency of gestational age
GA
8 5.3 5.3 5.3
22 14.7 14.7 20.0
38 25.3 25.3 45.3
49 32.7 32.7 78.0
28 18.7 18.7 96.7
5 3.3 3.3 100.0
150 100.0 100.0
32
34
36
38
40
42
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
The majority of babies 49 out of 150 that is 32.7% are 38 weeks of corrected 
gestational age.
Followed by 36 weeks (38%), 40 weeks (18.7%), 34 weeks (22%), 32 weeks 
(8%), and least was 42 weeks (5%).
Table-3
Sex distribution in different groups
 SEX * Type 
Crosstabulation 
14 16 15 15 11 17 88 
56.0
% 
64.0
% 
60.0
% 
60.0
% 
44.0
% 
68.0
% 
58.7
% 11 9 10 10 14 8 62 
44.0
% 
36.0
% 
40.0
% 
40.0
% 
56.0
% 
32.0
% 
41.3
% 25 25 25 25 25 25 150 
100.0
% 
100.0
% 
100.0
% 
100.0
% 
100.0
% 
100.0
% 
100.0
% 
 FEMALE 
   MALE 
  TOTAL 
 Rocking     NNS  SUCROSE ROCK & NNS SUCROSE & 
   NNS 
CONTROL 
Type 
Total 
P =0 .62 (NS) 
             Except in sucrose & NNS in which males were more, all other groups’ 
females were more.
        
Table-4
Comparison of Mean gestational and neonatal age between the groups
 
Repor
t 
37.8
4 
1.60 
25 25 
1.72 .76 
36.7
2 
1.84 
25 25 
2.15 .75 
38.8
8 
4.52 
25 25 
2.89 6.03 
36.8
0 
1.84 
25 25 
1.53 .99 
36.0
0 
1.20 
25 25 
1.63 .50 
36.3
2 
3.28 
25 25 
2.98 4.05 
37.0
9 
2.38 
150 150 
2.40 3.20 
Mean 
N 
Std. Deviation 
Mean 
N 
Std. Deviation 
Mean 
N 
Std. Deviation 
Mean 
N 
Std. Deviation 
Mean 
N 
Std. Deviation 
Mean 
N 
Std. Deviation 
Mean 
N 
Std. Deviation 
Typ
e Rocking 
NNS 
Sucrose 
Rock & NNS 
Sucrose & NNS 
Control 
Total 
GA NA 
The mean age is highest in sucrose (38.88 weeks) and lowest in sucrose&NNS 
(36 weeks).
Table-5
Comparison of type of delivery between the groups
 DELIVERY * Type 
Crosstabulation 
25 11 9 25 7 77 
100.0
% 
44.0
% 
36.0
% 
100.0
% 
28.0
% 
51.3
% 14 16 25 18 73 
56.0
% 
64.0
% 
100.0
% 
72.0
% 
48.7
% 25 25 25 25 25 25 150 
100.0
% 
100.0
% 
100.0
% 
100.0
% 
100.0
% 
100.0
% 
100.0
% 
Count 
% within 
Type Count 
% Within 
Type Count 
% Within 
Type 
   LSCS 
VAGINAL 
DELIVERY 
Total 
 Rocking   NNS  SUCROSE  ROCK & NNS 
SUCROSE 
& NNS Control 
Typ
e 
 Total 
Among the 150 babies 77 (51.3%) were delivered by LSCS and 73 (48.7%) 
were delivered by vaginal.
P < 0.005 (S)
Table-6
DELIVERY
77 51.3 51.3 51.3
73 48.7 48.7 100.0
150 100.0 100.0
LSCS
VAGINAL
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
Table-7
 
Report 
WT 
2.812
4 
25 .312
8 2.456
0 
25 .466
7 2.466
0 
25 .582
9 2.645
2 
25 .498
9 2.407
2 
25 .455
2 2.451
2 
25 .695
7 2.539
7 
150 .527
0 
Type 
Rocking 
NNS 
Sucrose 
Rock & NNS 
Sucrose & NNS 
Control 
Total 
Mean N Std. Deviation 
Mean birth weight is highest in rocking (2.8kg) and lowest in sucrose&NNS 
(2.4kg)
Table-8
Comparison of mean time (hours) since last feed in between the groups
 Report 
TIME 
1.720
0 
25 .7371 
1.660
0 
25 .7735 
1.250
0 
25 .6166 
1.500
0 
25 .7773 
1.480
0 
25 .5099 
.8480 25 .4788 
1.409
7 
150 .7123 
Type 
Rocking 
NNS 
Sucrose 
Rock & NNS 
Sucrose & NNS 
Control 
Total 
Mean N Std. Deviation 
Time is lowest in control (0.8 hours) and highest in rocking (1.72 hours)
Table-9
Mean values of demographic characters
Frequencies
Statistics
150 150 150 150
0 0 0 0
37.09 2.38 2.5397 1.4097
.20 .26 4.303E-02 5.816E-02
38.00 1.50 2.6400 1.0000
2.40 3.20 .5270 .7123
Valid
Missing
N
Mean
Std. Error of Mean
Median
Std. Deviation
GA NA WT TIME
Table-10
Mean heart rate rise and oxygen saturation fall
Frequencies
Statistics
150 150 150 150 150
0 0 0 0 0
135.5933 157.6533 22.0200 99.5733 94.7267
.5435 1.3467 1.2450 4.668E-02 .2298
136.0000 155.0000 20.0000 100.0000 95.0000
6.6566 16.4932 15.2480 .5717 2.8139
Valid
Missing
N
Mean
Std. Error of Mean
Median
Std. Deviation
HR1 HR2 HR2-HR1 OS1 OS2
Table-11
Mean of fall in oxygen saturation and behavioral indicators
Frequencies
 
Statistics 
15
0 
15
0 
15
0 
15
0 0 0 0 0 
4.89
39 
37.88
67 
33.56
67 
34.35
33 .22
66 
5.91
24 
2.23
51 
2.26
13 4.04
00 
20.00
00 
25.00
00 
25.00
00 2.77
50 
72.41
24 
27.37
40 
27.69
56 
Valid 
Missing 
N 
Mean 
Std. Error of Mean 
Median 
Std. Deviation 
OS3 BB
% 
ES
% 
NLF
% 
Table-12
Mean of behavioral state before the procedure and PIPP
Frequencies
Statistics
150 150
0 0
1.9600 9.0667
.5311 .3603
1.0000 9.0000
6.5044 4.4127
Valid
Missing
N
Mean
Std. Error of Mean
Median
Std. Deviation
BSBP PIPP
                                                         
Table-13
Recoding of PIPP
pipprec
33 22.0 22.0 22.0
75 50.0 50.0 72.0
23 15.3 15.3 87.3
19 12.7 12.7 100.0
150 100.0 100.0
0-5
6-10
11-15
16-20
Total
Valid
Frequency Percent Valid Percent
Cumulative
Percent
50% are fall between score of 6-10, which is the highest.
Table-14
Comparison of mean PIPP between the groups
PIPP  * Type
 
Report 
PIPP 
11.520
0 
25 2.143
2 
11.000
0 
.428
6 8.880
0 
25 1.235
6 
9.000
0 
.247
1 6.280
0 
25 2.354
4 
5.000
0 
.470
9 7.400
0 
25 1.118
0 
7.000
0 
.223
6 3.880
0 
25 1.810
2 
4.000
0 
.362
0 16.440
0 
25 1.660
3 
17.000
0 
.332
1 9.066
7 
150 4.412
7 
9.000
0 
.360
3 
Type 
Rocking 
NNS 
Sucrose 
Rock & NNS 
Sucrose & NNS 
Control 
Total 
Mean N Std. Deviation Median 
Std. Error 
of Mean 
        The mean PIPP is lowest for sucrose & NNS group (3.88) followed by 24% 
sucrose solution (6.28), rocking & NNS (7.4), NNS (8.8), rocking (11.52), and 
highest for control (16.4).
         That the table clearly shows, sucrose &NNS is the best non-
pharmacological method to reduce the pain.
        ANOVA value, 
                                  F=154.958
                                  Degree of freedom=5
                                  P<0.0005 -significant
Table-15
Comparison PIPP between the sexes
PIPP  * SEX
Report
PIPP
9.6818 88 4.2738 9.0000 .4556
8.1935 62 4.4935 7.0000 .5707
9.0667 150 4.4127 9.0000 .3603
SEX
FEMALE
MALE
Total
Mean N Std. Deviation Median
Std. Error
of Mean
Female are having mean value of 9.68, which is higher than male value of 8.1. It 
shows that females are crying more than males.
Table-16
Comparison of PIPP between types of deliveries
PIPP  * DELIVERY
Report
PIPP
8.6494 77 4.4656 9.0000 .5089
9.5068 73 4.3433 8.0000 .5083
9.0667 150 4.4127 9.0000 .3603
DELIVERY
LSCS
VAGINAL
Total
Mean N Std. Deviation Median
Std. Error
of Mean
The babies delivered by LSCS (mean PIPP-8.6) are crying lesser than those 
delivered by vaginal (mean PIPP-9.5).
Table-17
Recoding of PIPP between the sexes
SEX * pipprec
Crosstab
14 44 16 14 88
15.9% 50.0% 18.2% 15.9% 100.0%
19 31 7 5 62
30.6% 50.0% 11.3% 8.1% 100.0%
33 75 23 19 150
22.0% 50.0% 15.3% 12.7% 100.0%
Count
% within SEX
Count
% within SEX
Count
% within SEX
FEMALE
MALE
SEX
Total
0-5 6-10 11-15 16-20
pipprec
Total
P = 0.9 
(NS) 
   In the 0-5 groups male babies are higher and gradually percentage of male 
babies are decreasing and those of female babies are increasing as the PIPP 
increases towards 16-20. This again showed female babies are crying more 
than the male babies.
Table-18
Comparison of PIPP recoding between the groups
Type * pipprec
Crosstab
11 12 2 25
44.0% 48.0% 8.0% 100.0%
24 1 25
96.0% 4.0% 100.0%
13 10 2 25
52.0% 40.0% 8.0% 100.0%
25 25
100.0% 100.0%
20 5 25
80.0% 20.0% 100.0%
8 17 25
32.0% 68.0% 100.0%
33 75 23 19 150
22.0% 50.0% 15.3% 12.7% 100.0%
Count
% within Type
Count
% within Type
Count
% within Type
Count
% within Type
Count
% within Type
Count
% within Type
Count
% within Type
Rocking
NNS
Sucrose
Rock & NNS
Sucrose & NNS
No Intervention
Type
Total
0-5 6-10 11-15 16-20
pipprec
Total
P < 0.0005 (S)
This table again shows that sucrose & NNS has got the best efficacy, followed 
by sucrose.
Table-19
Comparison of PIPP recoding between the type of deliveries
DELIVERY * pipprec
Crosstab
23 32 15 7 77
29.9% 41.6% 19.5% 9.1% 100.0%
10 43 8 12 73
13.7% 58.9% 11.0% 16.4% 100.0%
33 75 23 19 150
22.0% 50.0% 15.3% 12.7% 100.0%
Count
% within DELIVERY
Count
% within DELIVERY
Count
% within DELIVERY
LSCS
VAGINAL
DELIVERY
Total
0-5 6-10 11-15 16-20
pipprec
Total
P = 0.01 (s)
Table-20
PIPP recoding for demographic data
Report
36.36 1.58 2.3415 1.3864
33 33 33 33
2.52 1.06 .5169 .5452
37.41 2.55 2.5883 1.5467
75 75 75 75
2.02 3.74 .4558 .7314
38.00 2.78 2.6826 1.2826
23 23 23 23
2.70 3.37 .5612 .7512
36.00 2.63 2.5189 1.0632
19 19 19 19
2.67 3.11 .6900 .7455
37.09 2.38 2.5397 1.4097
150 150 150 150
2.40 3.20 .5270 .7123
Mean
N
Std. Deviation
Mean
N
Std. Deviation
Mean
N
Std. Deviation
Mean
N
Std. Deviation
Mean
N
Std. Deviation
pipprec
0-5
6-10
11-15
16-20
Total
GA NA WT TIME
                                                           Table-21
Comparison of mean heart rate rise between the groups
HR 2 – HR 1
HR2-HR1  * Type
Report
HR2-HR1
22.3600 25 9.9494 21.0000 1.9899
18.8800 25 4.3428 21.0000 .8686
21.3200 25 13.2656 24.0000 2.6531
18.8400 25 5.6101 18.0000 1.1220
7.8400 25 4.1097 6.0000 .8219
42.8800 25 20.4233 40.0000 4.0847
22.0200 150 15.2480 20.0000 1.2450
Type
Rocking
NNS
Sucrose
Rock & NNS
Sucrose & NNS
No Intervention
Total
Mean N Std. Deviation Median
Std. Error
of Mean
Maximal rise in heart rate for control (42.88), and minimum for sucrose & NNS 
(7.8).
Table-22
Comparison of rise in heart rate between the sexes
HR2-HR1  * SEX
Report
HR2-HR1
24.0341 88 16.2505 21.0000 1.7323
19.1613 62 13.3087 17.0000 1.6902
22.0200 150 15.2480 20.0000 1.2450
SEX
FEMALE
MALE
Total
Mean N Std. Deviation Median
Std. Error
of Mean
Table-23
Comparison of rise in heart rate between the type of deliveries
HR2-HR1  * DELIVERY
Report
HR2-HR1
17.9870 77 12.7769 14.0000 1.4561
26.2740 73 16.5255 21.0000 1.9342
22.0200 150 15.2480 20.0000 1.2450
DELIVERY
LSCS
VAGINAL
Total
Mean N Std. Deviation Median
Std. Error
of Mean
Table-24
Comparison of fall in oxygen saturation between the groups
OS 3 
Report
OS3
6.6300 25 2.1640
3.8976 25 1.0700
5.4264 25 2.6957
3.3260 25 .8019
1.8028 25 1.0434
8.2804 25 2.0131
4.8939 150 2.7750
Type
Rocking
NNS
Sucrose
Rock & NNS
Sucrose & NNS
No Intervention
Total
Mean N Std. Deviation
Minimal fall in saturation for sucrose & NNS, and maximal fall for control group.
Table-25
Comparison of mean percentage of brow bulge time between the groups
 
Report 
BB% 
56.400
0 
25 18.580
9 29.800
0 
25 16.550
4 8.200
0 
25 8.765
5 21.800
0 
25 7.889
9 8.000
0 
25 6.123
7  70.800 25 157.423
3 37.886
7 
15
0 
72.412
4 
Type 
Rocking 
NNS 
Sucrose 
Rock & NNS 
Sucrose & NNS 
No Intervention 
Total 
Mean N Std. Deviation 
ean time is lowest in sucrose & NNS, and highest in control.
Table-26
Comparison of mean percentage of time for eye squeeze, nasolabial furrow and 
behavioral state before the procedure between the groups
Report
60.6000 61.1200 1.0800
25 25 25
17.1391 17.0130 1.1150
30.6000 31.0000 1.2400
25 25 25
15.0914 15.4785 .9695
8.2000 8.0000 1.9600
25 25 25
8.7655 8.8976 1.2069
23.2000 23.8000 1.2800
25 25 25
7.6212 8.2006 .7916
8.0000 8.0000 1.2000
25 25 25
7.3598 7.6376 .9129
70.8000 74.2000 5.0000
25 25 25
16.2455 7.3144 15.6684
33.5667 34.3533 1.9600
150 150 150
27.3740 27.6956 6.5044
Mean
N
Std. Deviation
Mean
N
Std. Deviation
Mean
N
Std. Deviation
Mean
N
Std. Deviation
Mean
N
Std. Deviation
Mean
N
Std. Deviation
Mean
N
Std. Deviation
Type
Rocking
NNS
Sucrose
Rock & NNS
Sucrose & NNS
No Intervention
Total
ES% NLF% BSBP
Table-27
Pearson’s correlation for PIPP with weight, time since last feed, gestational age, and 
neonatal age.
FACTOR PEARSON 
VALUE (R)
P VALUE SIGNIFICANCE
WEIGHT +0.046 0.573 NS
TIME -0.192 0.019 S
NEONATAL 
AGE
+0.110 0.182 NS
GESTATIONAL 
AGE
-0.031 0.707 NS
DISCUSSION
     The present study is a randomized, partially blinded study to compare the 
analgesic  effects  of  common  non-pharmacological  methods  to  reduce  pain  in 
neonates.
     Complete blinding was not possible as many of the interventions had to be continued 
during the venipuncture.
     Previous studies have demonstrated that veni puncture would be a better option for 
blood sampling compared to heel stick36, 37. However, Bautcher et al (1992) has shown 
that analgesics for venipuncture was used in only 2% of the subjects exposed.
     PIPP was selected as the scoring tool of pain analysis mainly because of fact, that it 
looks into account the baseline behavioral status of the neonates, which would influence 
the pain response of the neonates38.
     Measures like containment, comforting and saddling were all avoided because the 
effects of the measures will depend on the interests of the parent / comfort provider.
      Because many studies have shown that previous painful experience might influence 
subsequent pain response, care was taken in include only neonates without previous pain 
experience.
     Mean total PIPP pain score was high in the control as compared to the intervention 
groups (see Table-14).
          A number of studies have compared the effects of sucrose with other non-
pharmacological methods of pain assessment.
          The cochrane analysis suggests that sucrose is better than placebo in reducing the 
effects of painful stimuli. In our study also sucrose is better than other methods (single 
method). 
          Stevens et al (1997) 39 have found sucrose to be superior to expressed breast milk.
         Carbajal et al (1999) 40 have shown pacifiers alone are better than sucrose.
        Campos et al (1994) 41 have shown rocking and pacifiers have been compared and 
both have ben found to reduce crying.
        Bellieni et al (2002) 42 have shown that multimodal stimulation is better than just 
sucrose. In our study also multimodal (sucrose & NNS) method relieved pain better than 
sucrose alone. 
        Corbo et al (2000) 43 have shown that NNS reduces the stress of pain.
        Gray et al (2002) 44 have found out that breast-feeding is better than others as has 
got multimodal stimulation.
        There was a significant rise in heart rate in the control group on exposure to 
venipuncture as compared to the intervention groups (see Table-21).
        Taksande amar et al (2005) 45 found out tha mean rise in heart rate in neonate to 
venipuncture was 14.12 beats/minutes. In our study it is 22.02 beats/ minutes, which is 
higher than their study.
       There was a significant decline in the variation of oxygen froe the baseline in the 
control group and was significantly different when compared to the base line variation in 
the groups (see Table-24).
                 Taksande amar et al (2005) and other studies observed similar changes in 
oxygen saturation from the baseline in response to venipuncture.
         It was observed that various behavioral responses were present for the maximum 
time and brow bulge was present longer than the eye squeeze and nasolabial furrow (see 
Table-25, 26).
        Roshfurth JA et al (1994) has observed similar results in his previous study where 
eye squeeze was present for the least duration.
       An interesting finding in our study is that female babies are crying more than male 
babies (Table- 15, 17).
         In our study babies those born by LSCS feel more pain than those born by vaginal 
delivery (Table-16).      
CONCLUSION
The present study puts forth the following conclusions based on study results.
• The simple and commonly used invasive procedure like venipuncture produces 
severe pain in a significant number of neonates with considerable physiological 
and behavioral changes.
• Female babies are more sensitive to pain than male babies.
• The babies born by LSCS feel more pain than those born by vaginal delivery.
• Non-pharmacological interventions reduce pain during venipuncture.
• Combining two methods reduces pain better than single method. 
• Providing  2ml  of  24%  sucrose  solution  2  minutes  prior  to  procedure  and 
establishing Non-nutritive sucking during and up till 2 minutes after the procedure 
is the best method. 
• Among  the  single  method,  2ml  of  24%  sucrose  solution  2  minutes  prior  to 
procedure is the best to reduce venipuncture pain. 
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PROFORMA
NEONATAL PAIN REDUCTION DURING VENIPUNCTURE BY NON-
PHARMACOLOGICAL ANALGESIA WITH PREMATURE INFANT PAIN 
PROFILE TOOL
Name                        :
IP no                         :
Random no              :
Group                       :
Gestational age       :
Neonatal age           :
Sex                         :
Birth weight           :
Weight at procedure:
Mode of delivery   :    vaginal/LSCS
Time since last feed:
Premature Infant Pain Profile:
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1M 40 2LSCS 2.4 2141161 20100 97 3 45 50 50 1 10
2F 38 1VAGINAL 2.7 2128149 21100 96 4 50 45 45 0 9
3F 34 2VAGINAL 1.7 1129150 21100 96 4 20 25 25 1 9
4F 36 3VAGINAL 2.2 3130151 21100 96 4 50 45 45 0 9
5F 36 3VAGINAL 2.1 1130148 18100 96 4 20 20 20 2 8
6M 36 2VAGINAL 2.330 min126147 21100 96 4 45 45 45 1 10
7F 34 1VAGINAL 1.8 2125146 21100 96 4 50 50 45 1 11
8F 38 3LSCS 2.7 1140150 10100 96 4 50 45 45 2 10
9F 40 2LSCS 2.4 2138158 20100 97 3 45 45 45 1 10
10F 34 1LSCS 2 1141152 11100 96 4 50 50 60 0 9
11F 38 2VAGINAL 3 3134154 20 99 963.03 10 15 15 3 9
12F 40 2VAGINAL 3 2135155 20 99 963.03 15 25 25 1 7
13M 36 2VAGINAL2.48 1135156 21 99 963.03 15 20 20 2 8
14M 40 1VAGINAL 3.3 3136157 21 99 963.03 20 20 20 0 6
15F 38 3VAGINAL 3 3136158 22100 97 3 15 20 20 3 9
16M 34 2VAGINAL1.76 1135157 22100 97 3 20 15 15 3 10
17M 38 1LSCS 2.68 1140162 12 99 936.06 20 20 20 2 9
18M 34 1LSCS 2.7 1141163 22 99 936.06 15 15 25 2 10
19F 38 2LSCS 2.88 2141151 10 99 954.04 45 50 50 0 8
20F 34 1LSCS 1.7 2138148 10 99 954.04 50 45 45 1 10
21F 38 1VAGINAL 2.8 1142164 22 99 936.06 10 15 10 1 8
22F 36 2LSCS 2.5 1140162 22 99 936.06 10 10 10 0 7
23M 38 3VAGINAL 3 1138160 22100 97 3 15 15 15 1 7
24F 34 1LSCS 1.9 2139161 22100 97 3 15 15 15 2 9
25M 36 2LSCS 2.4 2140160 20100 97 3 45 45 45 1 10
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1 F 42 2 VAGINAL 2.6 1 13015929 99 954.04 5 5 5 3 7
2 F 38 2 LSCS 1.85 30min 12815628 99 954.04 5 5 5 3 7
3 F 36 1 VAGINAL 1.7 2 13414814 99 954.04 5 5 0 2 5
4 F 40 1 LSCS 2.5 45min 125134 9 99 954.04 0 0 0 3 5
5 F 38 22VAGINAL 1.8 1 1461742810088 12 5 5 5 3 9
6 F 32 2 VAGINAL1.63 45min 156165 9 99 954.04 5 5 5 2 5
7 M 40 8 LSCS 2.3 2 14617024 99 954.0425 25 25 1 7
8 M 40 5 VAGINAL 3 1 128136 8 10095 5 5 5 5 0 3
9 M 40 5 VAGINAL 3.2 1 125134 9 10095 5 5 5 5 0 3
10 F 42 2 VAGINAL 2.6 1hour 30 min13215725 99 954.04 5 5 5 3 7
11 F 38 2 LSCS 1.85 30min 12815628 99 954.04 5 5 5 3 7
12 F 36 1 VAGINAL 1.7 2 13414814 99 954.04 0 0 0 2 5
13 M 40 8 LSCS 2.5 2 14617024 99 954.0425 25 25 1 7
14 F 40 1 LSCS 2.8 45 min 130137 7 99 954.04 0 0 0 3 5
15 F 38 25VAGINAL 2 2 1301582810092 8 5 5 5 3 9
16 M 34 2 VAGINAL 1.7 1 13414814 99 954.04 0 0 0 2 5
17 M 32 2 VAGINAL1.74 1 156165 9 99 954.04 5 5 5 2 5
18 M 40 3 VAGINAL 2.8 1 12815830 99 936.06 5 5 5 0 5
19 F 42 3 LSCS 3 30min 13015929 99 954.04 5 5 5 3 7
20 M 40 2 VAGINAL2.78 30min 1342036910093 7 5 5 5 0 5
21 F 40 2 LSCS 3 2 125134 9 10097 3 5 5 5 3 5
22 F 42 3 LSCS 3.15 30min 1461742810088 12 25 25 25 3 12
23 M 40 4 VAGINAL 3 2 14617024 99 954.0425 25 25 1 7
24 M 40 3 VAGINAL 3.4 2 125134 9 10095 5 5 5 5 0 3
25 F 42 2 VAGINAL3.05 2 1461742810088 12 25 25 25 3 12
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1 M 38 3 VAGINAL3.16 2 1351491410097 3 20 25 25 2 7
2 F 38 2 VAGINAL3.05 2 1361501410097 3 15 20 20 1 6
3 F 38 2 VAGINAL 3.4 2 1381541610096 4 20 25 20 1 7
4 F 38 1 VAGINAL3.16 3 1281542610097 3 25 25 25 1 8
5 M 34 1 VAGINAL 1.9 30min1301441410097 3 25 25 25 0 6
6 F 34 2 VAGINAL1.92 1 1281401210097 3 25 25 20 1 7
7 F 38 1 VAGINAL2.78 1 1421622010096 4 25 25 25 3 9
8 F 36 2 VAGINAL2.88 2 1461561010097 3 20 15 15 2 7
9 M 36 1 VAGINAL2.75 2 13815820 98 96 2.04 15 10 10 2 8
10 F 36 3 VAGINAL 2.7 1 1341602610095 5 20 25 25 2 10
11 F 38 2 VAGINAL 3 1 1301441410096 4 30 30 25 1 6
12 F 38 4 VAGINAL 3 3 1381582010097 3 25 25 35 1 7
13 M 38 2 VAGINAL 3 2 1381541610097 3 20 25 35 1 7
14 F 38 4 VAGINAL 1.9 1 1261542810097 3 20 25 25 1 8
15 M 38 1 VAGINAL 3 30min1201503010095 5 25 25 20 1 9
16 F 38 3 VAGINAL 3 2 14016222 99 96 3.03 30 25 25 1 7
17 M 36 1 VAGINAL 2.5 1 1401642410096 4 15 10 10 1 7
18 F 36 1 VAGINAL2.25 1 1351481310098 2 10 15 15 2 6
19 M 38 2 VAGINAL2.92 1 13815820 98 94 4.08 15 25 25 1 7
20 M 38 1 VAGINAL 3.2 1 1401581810097 3 15 20 20 0 6
21 M 38 1 VAGINAL 2.5 3 1281562810096 4 25 25 20 0 7
22 M 34 3 VAGINAL 1.8 30min1401602010097 3 15 20 30 2 9
23 F 36 1 VAGINAL2.08 2 1361541810096 4 15 15 25 1 7
24 F 36 1 VAGINAL2.48 1 1301441410098 2 50 50 50 1 8
25 F 34 1 VAGINAL 1.8 1 1441581410097 3 25 25 25 3 9
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1 M 36 1 LSCS 2.4 1 130136 6 99 96 3.03 5 5 5 1 3
2 M 36 2 LSCS 2.4 1 128132 4 100 99 1 5 0 5 2 2
3 M 36 1 LSCS 2.4 1 130136 6 100 99 1 5 5 5 3 4
4 F 36 1 LSCS 2.4 1 130140 10 100 98 2 10 15 15 0 4
5 F 36 1 LSCS 2.4 2 134144 10 100 97 3 5 5 0 2 4
6 M 36 1 LSCS 2.4 1 140150 10 100 98 2 5 5 5 1 2
7 M 36 1 LSCS 2.4 2 134144 10 100 97 3 0 0 0 0 2
8 M 36 1 LSCS 2.4 2 136144 8 99 98 1.01 5 5 5 1 2
9 F 36 1 LSCS 2.5 1 128134 6 100 99 1 5 5 0 2 3
10 F 34 1 LSCS 2 1 128130 2 100 97 2 5 0 0 2 4
11 F 34 1 LSCS 1.8 1 144148 4 100 98 2 15 10 10 0 4
12 F 38 2 LSCS 2.96 1 138154 16 100 97 3 15 15 15 1 7
13 F 38 1 LSCS 3 1 140154 14 99 96 3.03 10 10 15 1 6
14 M 38 1 LSCS 3 2 140145 5 100 98 2 15 15 15 0 4
15 M 38 1 LSCS 3 1 140154 14 100 97 3 20 25 25 2 7
16 F 38 1 LSCS 3 2 144156 12 100 97 3 20 25 25 1 6
17 F 38 1 LSCS 3 2 128134 6 100 99 1 10 10 10 0 4
18 M 38 3 LSCS 2.9 2 134150 16 100 97 3 15 15 15 2 8
19 M 38 1 LSCS 2.8 2 134138 4 100100 0 0 0 0 1 1
20 F 34 1 LSCS 1.9 2 140144 4 100 99 1 5 5 5 1 2
21 M 34 1 LSCS 1.8 1 140145 5 100 99 1 0 0 0 2 4
22 F 34 2 LSCS 1.92 2 130134 4 99 99 0 0 0 0 1 2
23 M 34 1 LSCS 1.8 1 140150 10 100 98 2 15 15 15 0 5
24 M 34 1 LSCS 1.8 2 144150 6 100100 0 5 5 5 1 3
25 M 34 1 LSCS 1.8 2 134138 4 100 98 2 5 5 5 3 4
CONTROL
KEY TO MASTER CHART
Sex                            : M-male
                                    F-female
GA:                           : Gestational age
Neonatal age             : Number of days after delivery
Mode of delivery      : LSCS- lower segment caesarean
                                                Section
                                    Vaginal- labour natural     
Weight                      : Birth weight in kilogram
Time                         : Time since last feed in hours.
HR1                          : Baseline heart rate
HR2                          : Maximal heart rate 
                                    during venipuncture.
HR2-HR1                 : Rise in heart rate
OS1                          :  Baseline oxygen saturation
OS2                          : Minimum oxygen saturation 
                                   during procedure
[OS1-OS2/OS1]x100: Fall in oxygen saturation 
          =OS3                 in percentage.
BB%                        : % of time of brow bulge during 
                                   Venipuncture
ES%                         : % of time of eye squeeze during 
                                   Venipuncture
NLF%                      : % of time of nasolabial 
                                  Furrow during venipuncture                               
BSBP                       : Behavioral state before the
                                  Procedure
PIPP                        : Premature Infant Pain Profile
ABBREVATIONS
ANOVA                 : Analysis Of  Variance
CGRP                     : Calcitonin gene regulated peptide
EMLA                    : Eutectic Mixture of Local 
                                  Anesthetics
G                            : Gauge
GABA                    : Gamma Amino Butyric Acid
IP                            : In patient
LSCS                     : Lower segment caesarean section
O2                         : Oxygen
P value                  : Probability value
PIPP                      : Premature Infant Pain Profile
PIPPrec                 :  Premature Infant Pain Profile  
                               Recoding
Std                        : Standard
TAC                     : Tetracaine, Amethocaine, Cocaine.

